News.ouhsc.edu
Patients Over 80 Benefit from Immunotherapy for Certain Cancers
OKLAHOMA CITY — Patients 80 and older who are treated with single-agent immunotherapies for some cancers benefit from these innovative treatments and have somewhat comparable outcomes to younger people who received the same type of treatments for similar cancers, according to a landmark study published November 4, in the journal JAMA Oncology. Abdul Rafeh Naqash, M.D., a clinical trials
Actived: 2 days ago
Top Categories
Popular Searched
› Department of health indianapolis indiana
› Sears home health care catalog
› Small business health insurance average costs
› Oscar health insurance providers florida
› Piedmont health care website
› Jackson health system accounts payable
› Advanced health assessment practice questions
Recently Searched
› Arcadia home health and home care services
› Player health script for roblox
› Advanced health curry county oregon
› Brookwood baptist health homewood al
› Jackson health system jet portal
› Alliance health corpus christi hours
› United healthcare medicaid north carolina
› Baptist health louisville outpatient pharmacy
› Advanced health cco provider portal